1826. Impact of Rapid Diagnostics and Ceftazidime–Avibactam on Mortality after Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae

BACKGROUND: Patients with bloodstream infections (BSIs) due to carbapenem-resistant Enterobacteriaceae (CRE) have long delays until receipt of appropriate antimicrobial therapy and high mortality rates. Rapid molecular diagnostics and novel therapies, such as ceftazidime–avibactam (CAZ-AVI), offer p...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Open Forum Infect Dis
Autors principals: Satlin, Michael J, Chen, Liang, Weston, Gregory, Gomez-Simmonds, Angela, Bhowmick, Tanaya, Seo, Susan K, Sperber, Steven, Kim, Angela, Eilertson, Brandon, Jenkins, Stephen, Levi, Michael, Uhlemann, Anne-Catrin, Weinstein, Melvin P, Tang, Yi-Wei, Hong, Tao, Juretschko, Stefan, Walsh, Thomas J, Westblade, Lars, Kreiswirth, Barry
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6808937/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz359.088
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars